See the published version of this preprint at Journal of Neurodevelopmental Disorders.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research
Ahmed Malalla Al-Ansari
Ministry of Health
Corresponding Author
ORCiD: https://orcid.org/0000-0001-9577-6298
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: To assess the prevalence of symptoms of depression, anxiety, and stress among mothers of children with autism spectrum disorders (ASD), type 1 diabetes, and typical development (TD), in a geographical area where such data are lacking.
Method: The study sample comprised a group of mothers of children with ASD (group 1; n=126), a group of mothers of children with diabetes mellitus (group 2; n=43), and a control group of mothers of children with TD (n=116).
Results: On the DASS-21, both groups 1 and 2 had higher mean scores for depression (37.86), anxiety (4.58), and stress (29.81) than the control group (P=0.015). On the PSS-14, the mean score was higher in group 2 (28.63) than in group 1 (27.61) and the control group (25.87) (p=0.004). On the DASS 21, group 1 scored higher in the depression domain (p=0.046), whereas group 2 scored higher in the anxiety domain (p=0.034) and stress domain (p=0.009) than the TD group.
Conclusion: Mothers of children with ASD should be assessed for the presence of depression following diagnosis. Mothers of children with type 1 diabetes require careful monitoring for the effects of anxiety and stress on their mental health and therefore their ability to cope with diabetes management plans.
Keywords
ASD, diabetes, DASS-21, PSS-14, Bahrain
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Journal of Neurodevelopmental Disorders.
Version (no preprint)
Posted 16 Apr, 2021
Review #2 received
Received 16 Apr, 2021
Reviewer #2 agreed
On 01 Apr, 2021
Reviewers invited
Invitations sent on 30 Mar, 2021
Reviewer #1 agreed
On 30 Mar, 2021
Review #1 received
Received 30 Mar, 2021
Editor assigned
On 28 Mar, 2021
Submission checks complete
On 28 Mar, 2021
Editor invited
On 28 Mar, 2021
This version was not preprinted
Version 2
Posted 25 Jan, 2021
No community comments so far
Editorial decision: Minor revision
On 02 Mar, 2021
Review #1 received
Received 13 Feb, 2021
Reviewer #2 agreed
On 04 Feb, 2021
Review #2 received
Received 04 Feb, 2021
Reviewers invited
Invitations sent on 02 Feb, 2021
Reviewer #1 agreed
On 02 Feb, 2021
Editor assigned
On 18 Jan, 2021
Submission checks complete
On 18 Jan, 2021
Editor invited
On 18 Jan, 2021
No comments provided
Editorial decision: Major revision
On 14 Dec, 2020
Review #2 received
Received 30 Oct, 2020
Review #1 received
Received 29 Oct, 2020
Reviewer #2 agreed
On 18 Oct, 2020
Reviewers invited
Invitations sent on 15 Oct, 2020
Reviewer #1 agreed
On 15 Oct, 2020
First submitted
On 01 Sep, 2020
Editor assigned
On 01 Sep, 2020
Submission checks complete
On 31 Aug, 2020
Editor invited
On 31 Aug, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
See the published version of this preprint at Journal of Neurodevelopmental Disorders.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research
Ahmed Malalla Al-Ansari
Ministry of Health
Corresponding Author
ORCiD: https://orcid.org/0000-0001-9577-6298
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Journal of Neurodevelopmental Disorders.
Version (no preprint)
Posted 16 Apr, 2021
Review #2 received
Received 16 Apr, 2021
Reviewer #2 agreed
On 01 Apr, 2021
Reviewers invited
Invitations sent on 30 Mar, 2021
Reviewer #1 agreed
On 30 Mar, 2021
Review #1 received
Received 30 Mar, 2021
Editor assigned
On 28 Mar, 2021
Submission checks complete
On 28 Mar, 2021
Editor invited
On 28 Mar, 2021
This version was not preprinted
Version 2
Posted 25 Jan, 2021
No community comments so far
Editorial decision: Minor revision
On 02 Mar, 2021
Review #1 received
Received 13 Feb, 2021
Reviewer #2 agreed
On 04 Feb, 2021
Review #2 received
Received 04 Feb, 2021
Reviewers invited
Invitations sent on 02 Feb, 2021
Reviewer #1 agreed
On 02 Feb, 2021
Editor assigned
On 18 Jan, 2021
Submission checks complete
On 18 Jan, 2021
Editor invited
On 18 Jan, 2021
No comments provided
Editorial decision: Major revision
On 14 Dec, 2020
Review #2 received
Received 30 Oct, 2020
Review #1 received
Received 29 Oct, 2020
Reviewer #2 agreed
On 18 Oct, 2020
Reviewers invited
Invitations sent on 15 Oct, 2020
Reviewer #1 agreed
On 15 Oct, 2020
First submitted
On 01 Sep, 2020
Editor assigned
On 01 Sep, 2020
Submission checks complete
On 31 Aug, 2020
Editor invited
On 31 Aug, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Journal of Neurodevelopmental Disorders.
Background: To assess the prevalence of symptoms of depression, anxiety, and stress among mothers of children with autism spectrum disorders (ASD), type 1 diabetes, and typical development (TD), in a geographical area where such data are lacking.
Method: The study sample comprised a group of mothers of children with ASD (group 1; n=126), a group of mothers of children with diabetes mellitus (group 2; n=43), and a control group of mothers of children with TD (n=116).
Results: On the DASS-21, both groups 1 and 2 had higher mean scores for depression (37.86), anxiety (4.58), and stress (29.81) than the control group (P=0.015). On the PSS-14, the mean score was higher in group 2 (28.63) than in group 1 (27.61) and the control group (25.87) (p=0.004). On the DASS 21, group 1 scored higher in the depression domain (p=0.046), whereas group 2 scored higher in the anxiety domain (p=0.034) and stress domain (p=0.009) than the TD group.
Conclusion: Mothers of children with ASD should be assessed for the presence of depression following diagnosis. Mothers of children with type 1 diabetes require careful monitoring for the effects of anxiety and stress on their mental health and therefore their ability to cope with diabetes management plans.
Loading...